Nothing Special   »   [go: up one dir, main page]

Borody et al., 2013 - Google Patents

Therapeutic potential of the human gastrointestinal microbiome

Borody et al., 2013

Document ID
11890192752324775783
Author
Borody T
Peattie D
Campbell J
Publication year
Publication venue
Drug Development Research

External Links

Snippet

Abstract Clinical Development Phases I‐III Regulatory, Quality, Manufacturing Scientific breakthroughs in deciphering the human gut microbiome and the clinical success of fecal microbiota transplantation (FMT) to treat recurrent C lostridium difficile infection (R‐CDI) are …
Continue reading at onlinelibrary.wiley.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Micro-organisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Micro-organisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Micro-organisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients

Similar Documents

Publication Publication Date Title
Ding et al. The spread of antibiotic resistance to humans and potential protection strategies
Dubin et al. Enterococci and their interactions with the intestinal microbiome
Seal et al. Microbial-derived products as potential new antimicrobials
Yadav et al. Microbiome therapeutics: exploring the present scenario and challenges
Imperial et al. Addressing the antibiotic resistance problem with probiotics: reducing the risk of its double-edged sword effect
Wan et al. Modulation of intestinal epithelial defense responses by probiotic bacteria
Khoruts et al. Understanding the mechanisms of faecal microbiota transplantation
Oakley et al. The chicken gastrointestinal microbiome
de Vos Fame and future of faecal transplantations–developing next‐generation therapies with synthetic microbiomes
Floch The role of prebiotics and probiotics in gastrointestinal disease
Culligan et al. Probiotics and gastrointestinal disease: successes, problems and future prospects
Lewis et al. Microbiota-based therapies for Clostridium difficile and antibiotic-resistant enteric infections
Suvorov Gut microbiota, probiotics, and human health
Ling et al. Clostridium butyricum combined with Bifidobacterium infantis probiotic mixture restores fecal microbiota and attenuates systemic inflammation in mice with antibiotic‐associated diarrhea
Babickova et al. Pathological and therapeutic interactions between bacteriophages, microbes and the host in inflammatory bowel disease
Takahashi et al. Faecal freezing preservation period influences colonization ability for faecal microbiota transplantation
Glenn et al. Emerging concepts on the gut microbiome and multiple sclerosis
Dhanani et al. Lactobacillus plantarum CS24. 2 prevents Escherichia coli adhesion to HT‐29 cells and also down‐regulates enteropathogen‐induced tumor necrosis factor‐α and interleukin‐8 expression
Wuethrich et al. The role of the human gut microbiota in colonization and infection with multidrug-resistant bacteria
Tellez et al. A peptidic fraction from milk fermented with Lactobacillus helveticus protects mice against Salmonella infection
Huang et al. A rapid screening method of candidate probiotics for inflammatory bowel diseases and the anti-inflammatory effect of the selected strain Bacillus smithii XY1
Draper et al. Autochthonous faecal virome transplantation (FVT) reshapes the murine microbiome after antibiotic perturbation
Borody et al. Therapeutic potential of the human gastrointestinal microbiome
Das et al. Probiotics as efficacious therapeutic option for treating gut-related diseases: Molecular and immunobiological perspectives
Zhou et al. Salmonella antimicrobials inherited and the non-inherited resistance: mechanisms and alternative therapeutic strategies